The new law allows providers to use telemedicine to prescribe most controlled substances, as long as they meet federal guidelines. It's an important step forward for a heavily-debated virtual care service.
A new law in Florida allows healthcare providers to prescribe many controlled substances via telemedicine, pushing the Sunshine State to the head of the pack in a heavily-debated virtual care service.
SB 312, signed this week by Governor Ron DeSantis, enables providers to use telemedicine to prescribe all but Schedule II drugs, while those prescriptions will be allowed via telemedicine if they meet one of four exceptions. Florida law had previously prohibited the prescribing of controlled substances via telemedicine except for a few situations.
The prescribing of controlled substances is a heavily regulated service, overseen at the federal level by the US Drug Enforcement Agency and the Ryan Haight Act, landmark legislation passed in 2009 that strongly limits how medications are prescribed online. Healthcare providers have to meet specific criteria to prescribe controlled substance via telemedicine, including conducting an in-person exam of the patient before moving to telehealth.
The healthcare industry, and telehealth advocates in particular, have long lobbied the federal government to ease those restrictions, saying they hinder access to care for those who can’t easily see a care provider in person and prevent a provider from reaching out to and treating more people in need of help (particularly in behavioral health and substance abuse services). The DEA has said in the past that it would relax those rules, but hasn’t done so yet, and federal waivers enacted during the pandemic to allow prescriptions by telemedicine will end with the public health emergency, which is scheduled to end later this year.
This makes Florida’s action particularly newsworthy.
“The law is a big win for Florida patients with medical conditions requiring controlled substances as part of the treatment regimen,” Nathaniel Lacktman, a partner with the Foley & Lardner law firm, chair of its telemedicine and digital health industry team and a national expert on digital health law, said in a recent blog post. “This includes, for example, endocrinology or substance use disorder (both of which use Schedule III medications now permitted under the new law), allowing these patients to obtain better access to more fulsome care. The law will also allow Florida clinicians to more easily prescribe refills in connection with their ongoing care management because the clinician can periodically conduct patient exams via telemedicine instead of requiring in-person exams even when those exams might be viewed as medically unnecessary.”
“Some stimulant medications commonly prescribed in psychiatry are Schedule II drugs, which could potentially meet one of the pre-existing exceptions if they are prescribed for treatment of a psychiatric disorder,” Lacktman added. “Most opioids are Schedule II drugs not allowed under this new law.”
Specifically, the new law amends Florida’s state statutes to allow providers to prescribe a controlled substance. That allowance is limited for Schedule II drugs to the treatment of a psychiatric disorder, inpatient treatment at a licensed hospital, hospice services, and treatment for residents in a nursing home.
Lacktman points out that the Florida law doesn’t supersede federal law, and providers need to make sure they meet both sets of laws. With the Ryan Haight Act, this means they still need to meet one of seven conditions that would allow them to prescribe a controlled substance via telemedicine without first scheduling an in-person exam.
But it puts Florida ahead of many states whose legislatures are still grappling with the idea of allowing doctors to remotely prescribe controlled medications. Opponents say the service offers too many opportunities for abuse, while supporters say it’s key component to improving clinical outcomes for underserved populations and others who can’t or won’t visit their doctor on a regular basis.
Partly in response to the pandemic, healthcare organizations have been launching remote patient monitoring (RPM) and hospital at home programs as a means of providing more services to patients at home and reducing hospital crowding. But federal and state governments have long had a heavy hand in regulating how healthcare can be delivered to the home.
Both federal and state regulators have kept firm control on telehealth by enforcing where it can be used and who can use it, to the point that advocates have long argued that government is hindering telehealth adoption. Only certain types of healthcare providers are allowed to use the technology to deliver healthcare services, and those services often must come from and go to specified healthcare settings, like a hospital, doctor's office, or clinic.
"Generally speaking, the hospital is a place," says Rachel Goodman, a partner with the Foley & Lardner law firm, specializing in digital health regulation. "In order to have a hospital license, you have to have that address," and regulators are cautious in approving services that extend outside that physical location.
In addition, she says, some within healthcare are questioning whether healthcare services for acute or critical care patients should be permitted at home, where the opportunities for clinical errors and even fraud are much more apparent.
The pandemic allowed for a surge in telehealth because the federal government and most states enacted several emergency measures aimed at expanding telehealth access and coverage. Those actions gave more care providers the freedom to use the technology, expanded the list of sites to include the home, and even expanded the types of technology that providers could use to include audio-only telehealth (e.g., over the phone) and RPM platforms.
Those measures are only in place until the end of the public health emergency (PHE), and while several states have permanently amended their telehealth rules to keep those expanded freedoms in place, there's still a lot of confusion—particularly at the federal level—about what happens when the PHE ends. This, in turn, has kept some health systems from developing long-term telehealth and RPM plans.
"It's certainly complicated," says Goodman. "We're not going back to the way we were [before the pandemic], but it's hard to tell what will happen right now."
This includes the Acute Hospital Care at Home program launched by the Centers for Medicare & Medicaid Services (CMS) in early 2020, as the pandemic was taking hold. The idea behind that new payment model was to give hospitals more leeway to treat patients with acute care needs at home, rather than having them take up a hospital bed at a time when those beds were in high demand for COVID-19 cases.
While hundreds of health systems have signed on to the program, there's little indication from CMS as to how long it will last. CMS is typically slow to reimburse for innovative services like telehealth, preferring to wait for several large-scale studies that prove the value of the new service in both reducing cost and improving outcomes. With the Acute Hospital Care at Home program just now gathering steam, that may take a few years.
Beyond the pandemic, Goodman sees the most growth in RPM around post-discharge services, such as rehabilitation and chronic care management, which are ideally suited for home monitoring. That's because those services apply to patients who have been discharged from the hospital.
"That's all really postacute care under a different name," she says.
For hospital at home and other services addressing acute care needs, she says, federal regulators will have to more clearly define whether a patient is discharged from a hospital into a home program (as opposed to a skilled nursing facility or similar rehab site), or whether that patient is still considered a part of the hospital's inpatient platform. That affects everything from quality and safety benchmarks to hospital staffing requirements.
Goodman expects it will take a few years for CMS to signal more aggressive adoption of hospital at home-style services. That'll prompt many health systems to go slowly with those platforms, as they need Medicare and Medicaid coverage to be able to sustain and scale up the offerings.
Supported by new technology that can access more data from any location, healthcare organizations are using remote patient monitoring strategies to bring care into the home.
With the healthcare industry's gradual shift to patient-centered care over the past two decades, healthcare organizations are realizing it's more effective to bring care to the patient, rather than forcing the patient to go somewhere to get care.
That strategy is based on the idea that healthcare is continuous, rather than episodic, and that a care provider will learn a lot more by going to the patient to learn about lifestyle, daily routines, and habits than waiting for that visit to the doctor's office, clinic, or hospital. It also requires a lot of data, from a lot of sources, so that a care provider can better understand the patient and the patient's environment while making decisions that impact care.
The remote patient monitoring (RPM) movement began roughly three decades ago, alongside the consumer health movement. Spurred by an interest in self-help health and wellness, consumers were showing an interest in improving their lifestyles through better diets, exercise, and healthy habits, and they were spurred on by a growing market in self-help resources, including technology such as activity bands, smartwatches, and online resources. Those with chronic conditions, such as diabetes, COPD, asthma, and congestive heart failure, were especially targeted with devices and resources that could help them manage their care at home, in between visits to the doctor.
Healthcare only gradually found interest in this. Early technology was designed to attract the consumer, rather than meet clinical care needs. The devices were stylish, but they weren't accurate enough to appeal to care providers, who wanted specific and reliable data that they could use to make clinical care decisions.
That changed, though, as a few forward-thinking providers and health systems realized that charting activity at home could help them influence patients to become more mindful of care management. Having someone living with diabetes measure their activity, for example, could lead to a healthier lifestyle that reduces negative health events, improves clinical outcomes, and curbs unnecessary health expenses; could help those with Alzheimer's or Parkinson's track the progression of their disease at home and improve functionality; or could help those living with cancer stay active during chemotherapy and boost their chances at recovery.
As time has passed, the technology is getting more sophisticated, with devices that can accurately measure vital signs and other biometric data at home or elsewhere and, through mHealth apps and online portals, send that information directly to care providers.
Health systems are now designing programs around these tools and capabilities. They're identifying populations that would benefit from RPM, giving them the devices they need and creating workflows that allow care providers to track them, gather data, communicate, and change care management plans when necessary. More sophisticated programs are adding smart devices in the home, charting factors such as home and family life, diet, and cultural influences; some programs are even combining virtual care with in-person visits from home health programs, specially trained paramedics, or care teams dispatched by the health system.
Easing into an RPM workflow
Less than 10% of the nation's health systems were using RPM prior to the COVID-19 pandemic, according to studies sponsored by the Brookings Institution, McKinsey & Company, and others. Many were small deployments, focused on specific populations or aiming to tackle a certain data point, such as reducing rehospitalizations in patients discharged after an inpatient stay.
That all changed with the pandemic, which pushed virtual care into overdrive. Everyone moved to reduce in-person care to decrease surging hospital traffic and lower the chances of spreading the virus, particularly to care providers and those at risk of serious complications. Many health systems tried out RPM platforms to care for COVID-19-infected patients at home, then modified their platforms to target other groups of patients who could benefit from remote monitoring.
At Heart of Florida Health Center, a federally qualified health center serving about 28,000 patients through seven clinics in rural Ocala, executives launched an RPM program in 2021 targeting uncontrolled hypertension with the help of a three-year grant from the Health and Human Services Department's Health Resources and Services Administration. The goal was to use the platform to help community members, many of whom face barriers to accessing in-person care, monitor and control their blood pressure, thus improving their health and reducing the chances of a heart attack, stroke, or other serious health issue.
"For us, this was getting our toes in the water," says Carali McLean, LCSW, Heart of Florida's director of quality, risk management, and compliance, noting the health center had tried an RPM program for diabetes care management without much success. "We wanted to have the ability to empower the patient to monitor their own health."
With the program, Heart of Florida is tackling a real health concern, one that kills more than half a million Americans a year. According to the Centers for Disease Control and Prevention, roughly 47% of American adults are diagnosed with hypertension, and yet only one in four have their blood pressure under control.
Through RPM, a patient takes blood pressure readings at least once a day (the frequency and times can be set by the provider if needed) and sends that data to Heart of Florida, where nurses review the readings and determine whether follow-up care is needed. If those readings go above or below a certain threshold established by the care team, an alert is triggered and a physician is called in. This could lead to an immediate intervention if serious, or a scheduled visit with a doctor.
Yasmin Ramasco, MSN, APRN, a nurse practitioner and support educator, says the platform allows Heart of Florida clinicians to regulate a patient's medications on the fly, adjusting them as needed to address changes in blood pressure. Previously, care providers would have had to wait to review data when the patient visited the doctor for a scheduled visit, sometimes weeks or months distant, and then modify the medications.
"We can better manage them and have them involved in that management," she says. "Our patients have been motivated and willing to participate."
McLean says Heart of Florida has seen a roughly 28% reduction in the number of patients with unchecked hypertension through the program, which translates to patients better managing their blood pressure and a reduced chance of adverse health events, including hospitalizations. With that success, the center has hired a nutritionist to work with patients to improve their eating habits.
"This is where we can make a difference," she says. "Preventive care's not a thing you go to a doctor for, like if a limb's broken," she points out. By using an RPM program, care providers can connect with patients when and where they're most comfortable talking about their health and life, and they can help patients make changes and forge new habits that take effect over time.
McLean expects that Heart of Florida will build on this success and branch out to other populations, including those living with diabetes.
Scaling up to manage more complex patients
While RPM programs often target patients who need help managing their care at home, some programs are springing up to handle those with critical care needs, including patients who would otherwise be in a hospital.
Much of the growth in what's being called the "hospital at home" movement is tied to the pandemic, and to a federal program aimed at supporting hospitals for caring for patients at home. The Centers for Medicare & Medicaid Services (CMS) launched its Acute Hospital Care at Home program in 2020, building off the agency's Hospitals Without Walls program, unveiled earlier that year to support the use of RPM and other services to offset the COVID-19 surge in hospitals.
The new program incentivizes health systems to create care programs for patients who would otherwise require hospitalization, combining in-person care with RPM devices and telehealth platforms for daily care management. And it inspired many health systems (more than 200 are part of the program as of the beginning of 2022) to rethink how they care for patients both inside and outside the walls of the hospital.
"The home hospital approach has repeatedly demonstrated its enormous benefit and value as an important treatment option for patients," past Massachusetts General Hospital President Peter Slavin, MD, said in a press release issued by CMS highlighting the first six health systems approved by CMS to join the program. "This innovative model has made available safe, cost-effective hospital-level care to patients at home—a reassuring environment that is comfortable, familiar, and healing. CMS' decision to cover home hospital care will not only make this program more viable but will also enable more patients and families to experience this high-quality high level of care in their own homes in their own communities."
California-based Adventist Health launched its Hospital@Home program in May 2020, focusing on eight specific diagnoses. Hospital executives say the CMS program gave them the support they needed to move forward, but they'd long been talking about reimagining healthcare delivery.
"We are moving from a healthcare organization to a health organization," says Lesa McArdle, RN, director of operations for the program, who notes the program is part of a strategy that maps out the health system's growth through 2030. "We are looking to increase our virtual and digital presence, and this fits right into that plan. It's a unique care model."
Adventist Health exemplifies the evolution of the RPM model, with a care plan in place for patients with more complex needs. In this format, patients are evaluated after they've been admitted to the hospital and sent back home with the appropriate devices and training if they meet the criteria for home-based care.
The program includes regular home visits by care providers, as well as virtual visits and RPM monitoring, depending on the care plan. And patients have four channels through which to contact their care team: through an iPad® (a care provider responds within an average of 17 seconds), through a dedicated phone number to an assigned nurse, through a waterproof PERS (personal emergency response) device, or through a biometric screening tool connected to the iPad that alerts care team members if the patient is in distress.
McArdle says safety and redundancy are crucial in a program like this. Wi-Fi and cellular connectivity are both included, in case one platform fails, and backup power is also on standby (a necessity in California, where weather-related power outages have been known to happen).
"When the patient is outside the walls of the hospital, how can you be sure?" she says, noting the program's goal is to replicate the in-person model of care as much as possible. "It's important that we have all this in place because we need to be able to know what the patient is doing at any time," just as if there were a nurse down the hall who could pop into a hospital room for a quick checkup.
Aside from a minimum five "vital touches" and two clinician visits per 24 hours, the service manages medications and even plans out meals. Home visits are scheduled through the telehealth vendor (in this case Medicity) or a home health service in California, while Adventist's Oregon facilities make use of a community paramedicine program.
The success of this program—or any hospital at home program—depends on the outcomes, and because the Acute Hospital Care at Home model was introduced roughly three years ago, a lot of that data hasn't been collected and put into reports just yet.
Some of the early CMS participants, such as Brigham and Women's Hospital in Boston, have published studies. A cardiac care pilot launched by David Levine, MD, MPH, MA, a physician and researcher in the Division of General Internal Medicine and Primary Care, found that the program reduced overall medical costs by 38% compared to in-person care, due in large part to fewer consults, imaging, and tests.
"This work cements the idea that, for the right patients, we can deliver hospital-level care outside of the four walls of the traditional hospital and provide more of the data we need to make home hospital care the standard of care in our country," Levine said in a 2019 press release issued by the hospital. "It opens up so many exciting possibilities—it's exciting for patients because it gives them the opportunity to be in a familiar setting, and it's exciting for clinicians because we get to be with a patient in that person's own surroundings. As a community-minded hospital, this is a way for us to bring excellent care to our community."
Adventist's program is seeing those results and proving popular with both clinicians and patients.
Per Danielsson, MD, the program's medical director, says the Hospital@Home program has reduced the health system's admission rate by 43% and all but eliminated infections and pressure ulcers in patients.
"Even though the patient is at home, there are so many touch points we have with them, and they're able to connect easily with us," he says.
Danielsson sees the program expanding as the health system builds out the infrastructure to support it, and as new RPM technology improves data capture at home. The program recently saw its first home dialysis patient, and future programs will be built around oncology, post-surgery, chronic care management, and hospice care.
"People are forecasting that the hospital of the future will be one large ICU," he says. "We'll be taking care of only the sickest patients in the hospital, and everything else can be done in the home. [The Hospital@Home program] is a step in that direction. It's beneficial to so many stakeholders."
But it isn't there yet. Danielsson also notes the concept is in its early stages, hindered by a healthcare industry that's slow to adapt to change. Some of the technology is still clunky, and federal and state regulations limit the use of telehealth and other digital health technologies at home. And payers must support the strategy, beginning with CMS.
"Things will change immensely over the next three or four years," he says.
Taking two steps forward, and one step back
In many cases, the success of RPM and hospital at home programs (especially those involved in CMS' Acute Hospital Care at Home program) has been due to the COVID-19 pandemic, which led to a surge in telehealth adoption across the country and emergency federal and state directives aimed at expanding access to and coverage of telehealth and digital health services. With the barriers dropped, RPM and hospital at home programs were launched in a matter of weeks, if not days, with the goal of separating healthcare workers and potentially infected patients and reducing the stress on crowded hospitals.
Some programs may have been launched on the idea that they'd last only as long as the public health emergency kept those state and federal emergency rules in place. But many healthcare executives saw the crisis as an opportunity to push innovation that would last well past the pandemic, and they developed strategies that would have taken years, perhaps decades, in more normal circumstances.
Executives at South Shore Health in southeastern Massachusetts had already launched a mobile integrated health (MIH) program that used specially trained paramedics to deliver care to targeted patients in the community. And they had an eye on the struggles faced by skilled nursing facilities (SNF), which were grappling with staffing shortages and high rates of rehospitalizations.
The health system launched its SNF at Home program in March 2021, with a goal of providing care at home for patients who would otherwise be living in those SNFs. The program was enhanced by the MIH platform, launched a year earlier.
Kelly Lannutti, DO, South Shore Health's director of clinical transformation and co-medical director of MIH, and program development and clinical innovation physician, says the program was designed to reduce stress on both the hospital and SNFs by giving more patients with complex care needs an opportunity to receive that care at home. It included round-the-clock real-time monitoring and in-person visits at least five times a week.
"It's really a shift in the acuity of the patients themselves who can be cared for at home," she says. "It's definitely a different mindset."
In many cases, programs like SNF at Home may be the next step in the RPM journey, as health systems develop the technology and workflows to care for more complex patients at home. But that step isn't without controversy, with critics wondering if home-based care is appropriate and safe enough for some patients with advanced care needs—especially those who would otherwise be in a structured healthcare setting like a hospital or SNF.
Lannutti says the program was structured to carefully review patients in the hospital before sending them home. It was also designed and launched during the height of the pandemic, when hospitals and SNFs were struggling to handle an excess of patients and saw home-based care as a good opportunity to cut traffic and curb the chance of infection.
"In the home setting it's very, very different," says Lannutti, noting that while the program was designed to replicate clinical care at home, it didn't equal the round-the-clock monitoring and care that a hospital or SNF offers.
South Shore Health has since dropped its SNF at Home program and adopted a platform that hews toward a hospital at home program. Lannutti says the decision was due in part to a lack of payer reimbursement for those services, which required a lot of time and effort from the health system, and some technological challenges around continuous monitoring.
"There's a difference between acute and critical care," she says, "and certain things we can't do at the home right now. We eased back."
The shift has given South Shore Health an opportunity to look more closely at what goes into home-based care, and to better define which patients are best suited for the program. They're now tailoring the RPM technology to the needs of the patient and creating workflows that benefit not only patients and caregivers, but also the nurses and doctors who keep tabs on them from the hospital.
"The home is a very different setting from the hospital," says Lannutti. "It forces care providers to think differently. You can't just take a nurse from the clinical setting and put them into [the program] and expect things to work out."
And nurses are a crucial part of the program.
"We would love to include more nurses," she says. "Everyone needs more nurses," and RPM and hospital at home programs fit snugly into nursing workloads, giving them the time and space to gather data, interact with patients, and call in doctors or specialists only when the situation demands it.
(Across the country at Adventist Health, the platform has been a welcome relief for nurses as well. McArdle points out that several nurses were pregnant when the program launched, and the health system saw this as an ideal way to keep them away from inpatient care and the heightened threat of catching the virus.)
It's evident that South Shore's program will evolve much differently than Adventist's, and that Adventist's is moving in a different direction than others. Healthcare executives are intrigued by the idea that these programs can be taken apart and put back together in many ways to meet the individual needs of the patient and the health system. One program might lean heavily on RPM tools to monitor vital signs on demand, while another could skew toward telehealth platforms that allow patients to check in with their care providers when they want or need to. Some programs may require daily visits from clinicians, while others may spread those visits out over the week or per a patient's specific needs.
South Shore is one of a handful of health systems that uses its own MIH program, a relatively new concept that falls into the community paramedicine mold. And that may grow in popularity as health systems look to acquire their own EMS services or partner with local ambulance companies and community health organizations to improve home-based care and reduce unnecessary 911 calls.
MIH "is an absolute game-changer," says Lannutti, who notes the paramedics "are thrilled to be able to do something other than taking people to the hospital."
Lannutti expects South Shore's program to expand, perhaps even going back to the SNF at Home model, as the health system explores its options. This includes talking to accountable care organizations and other risk-bearing programs, many of whom have a significant interest in the postacute care space and want to see alternatives to expensive clinical care.
"We've learned a lot of lessons, all of them positive," she says. "We have a better understanding of what the patient wants now, and they now realize that they can receive care from their home."
That may be a more important factor than anyone realizes. With all the talk of patient-centered care, it's the patient who may dictate how RPM and hospital at home programs evolve. Patients will ask for more care at home, and perhaps base their future healthcare interactions on who can provide those services. Savvy health systems will offer more of these programs to additional populations, taking advantage of newer devices, even wearables and smart home technology.
"We all go into healthcare to make a difference in people's lives," says McArdle, of Adventist Health. "And with this model, we have nurses and doctors in the patient's home virtually, sometimes even physically. We become a part of their lives. We truly have a more holistic view."
A remote patient monitoring program launched by Penn Medicine to treat COVID-19 patients at home is working fine and proving its value. Adding technology didn't make it any better.
New technology doesn’t always add value to a good remote patient monitoring program.
That’s the take-away from a study of a COVID-19 RPM program managed by Penn Medicine and recently published in the New England Journal of Medicine. The study of more than 2,000 patients enrolled in the health system’s COVID Watch program in 2020 and 2021 found that patients who used a pulse oximeter at home didn’t have better outcomes than patients who simply contacted their care providers when they had breathing problems.
“Compared to remotely monitoring shortness of breath with simple automated check-ins, we showed that the addition of pulse oximetry did not save more lives or keep more people out of the hospital,” Anna Morgan, MD, medical director of the COVID Watch program, an assistant professor of General Internal Medicine and the study’s co-author, said in a Penn Medicine press release. “And having a pulse oximeter didn’t even make patients feel less anxious.”
To be sure, the program – which has treated more than 28,500 patients - still proves that an RPM platform can be an important tool in monitoring patients outside the hospital, reducing hospital traffic, and improving clinical outcomes.
“The program made it easy to identify the sickest patients who needed the hospital, and keep the others at home safely,” David Asch, MD, executive director of the Center for Health Care Innovation and a professor of Medicine, Medical Ethics and Health Policy, said in the press release. “The program was associated with a 68 percent reduction in mortality, saving a life approximately every three days during peak enrollment early in the pandemic.”
But that doesn’t mean it needs more technology.
Launched in March 2020, the program uses a text messaging platform to keep track of patients diagnosed with COVID-19 who were well enough to stay at home. The automated system sends text messages to those patients twice a day for two weeks, asking how they feel and if they’re having difficulty breathing. If patients indicate they are having problems, a nurse will call them and either suggest continued monitoring, schedule an urgent telemedicine appointment or direct the patient to the hospital’s Emergency Department.
Penn Medicine then decided to see if more technology would make the program better. Acting on research from the Perelman School of Medicine that patients might not notice when their blood oxygen levels are dropping to dangerous levels, the RPM program sent some patients home with a pulse oximeter.
“Several health systems, and even states like Vermont and countries like the United Kingdom, have integrated pulse oximetry into the routine home management of patients with COVID-19, but there’s been scant evidence to show this strategy makes a difference,” M. Kit Delgado, MD, an assistant professor of Emergency Medicine and Epidemiology and the research project’s principal investigator, said in the press release.
With support from the Patient-Centered Outcomes Research Institute (PCORI), Delgado and her colleagues then studied outcomes from roughly 2,000 patients enrolled between March 2020 and February 2021, randomly divided between those using pulse oximeters and those not using the device. And they found no difference in outcomes.
“Overall, these findings suggest that a low-tech approach for remote monitoring systems based on symptoms is just as good as a more expensive one using additional devices,” Krisda Chaiyachati, MD, an assistant professor of Internal Medicine and the research project’s co-principal investigator, said in the press release. “Automated text messaging is a great way for health systems to enable a small team of on-call nurses to manage large populations of patients with COVID-19,”
The study offers a lesson for any health system looking to launch a new technology platform or use an new tool: Don’t just assume it will make things better.
“There are a lot of other medical conditions where the same kind of approach might really help,” he added.
The Medical University of South Carolina and The Citadel have agreed to a partnership that will allow cadets at the Charleston military college to access healthcare services, including via virtual care, through the health system
Virtual care is coming to The Citadel
The famed military college in Charleston has forged a partnership with the Medical University of South Carolina (MUSC) to provide healthcare services for its roughly 3,300 cadets.
The multi-phased program includes access to MUSC’s 24/7 Virtual Urgent Care program, which enables staff at the college’s infirmary to connect with healthcare providers at MUSC through a telemedicine platform. Students will also be able to manage their healthcare interaction through the health system’s digital health portal.
“Some of the many benefits this affiliation provides include integrated health care access for cadets who can use the MUSC digital medical records portal to manage their care, prescriptions and appointments, and will now have 24-hour access to their medical records and appointments as well as continuing to have 24-hour access to medical care,” Charles Cansler, vice president for finance and business at The Citadel, said in a press release. “Additionally, cadets will be treated with the latest medical technology both on campus and at other MUSC facilities as needed. And over time, upgrades will be made to the infirmary equipment, processes and the building itself.”
As part of the agreement, MUSC Health will bill insurers for care provided at the college and the college will cover co-pays for cadets.
“Health care is undergoing a major transformation right now – from digitization and automation of certain services to how and when individuals access in-person care,” Eugene Hong, MD, MUSC Health’s chief physician executive, said in the release. “As the needs of the community change with the times, we look forward to doing our part to help The Citadel ensure the health and well-being of the Corps.”
One of six senior military colleges in the US, The Citadel was founded in 1842, 18 years after MUSC, also in Charleston, was opened. Its students are called the South Carolina Corps of Cadets, and come from 45 states and 23 other countries.
Penn State researchers have developed an mHealth app that allows care providers and pharmacists to identify drug-drug interactions at the point of care for patients using marijuana or CBD
Penn State is taking aim at the growing popularity (and legalization) of marijuana and cannabidiol (CBD) products with an mHealth app designed to help providers identify how those products might interact with other medications.
The CANNabinoid Drug Interaction Review (CANN-DIR) app is a free web-based resource targeted at healthcare providers and pharmacists. Developed by researchers at the Penn State College of Medicine, it allows users to select the cannabinoid product that a patient is taking and provide information on how it reacts to over-the-counter and prescription medications.
“Some drugs can affect the way others are broken down by the body, which can be problematic in the case of medications with a narrow therapeutic index,” Kent Vrana, the project leader and Eliot S. Veseli Professor and Chair of the Department of Pharmacology, said in a press release. “People may not realize that THC (delta-9-tetrahydrocannabinoil) and CBD products have the ability to change the way other drugs are metabolized, and it’s an important conversation for patients and health care providers to have with each other. CANN-DIR can help facilitate those conversations and provide useful information for health care providers when prescribing medications to their patients.”
The app is an ideal example of how clinical decision support is going digital, through online resources that can be accessed on laptops, tablets and other mobile devices at the point of care.
“The goal of CANN-DIR is to provide health care providers an additional resource to improve patient safety by reducing unintended drug-drug interactions,” added Paul Kocis, a clinical pharmacist at the Penn State Health Milton S. Hershey Medical Center who created the database with Vrana. “We hope this resource will also focus attention on how cannabinoids can affect the metabolism of other medications.”
According to the National Conference of State Legislatures, 18 states, as well as Washington DC and Guam, have legalized the recreational use of marijuana, while 37 states, Washington DC, Guam, Puerto Rico and the US Virgin Islands have approved the medical use of marijuana. And just this month, the US House of Representatives voted to decriminalize marijuana, though a similar bill now before the Senate isn’t expected to pass.
The pandemic created a surge in virtual care as state and federal lawmakers relaxed the rules to expand telehealth access and coverage, but now some states are looking to tighten the regulations
With COVID-19 slowly moving into the rear-view mirror, some states are dialing back the telehealth freedoms that healthcare providers enjoyed during the pandemic.
In Alabama, Senate Bill 272 and House Bill 423 aim to mandate in-person visits for certain virtual care services, with supporters arguing that a visit to the doctor's office is needed to maintain the physician-patient relationship and to ensure quality care.
Specifically, the Alabama bills would mandate:
At least one in-person visit every 12 months for physicians who meet with a patient four or more times a year via telehealth (current language allows for in-person care when necessary to meet the standard of care); and
An in-person visit whenever a physician prescribes a controlled substance (current language allows for prescription of controlled substances via telehealth if that service meets state and federal regulations and telehealth is consistent with the standard of care).
The debate over a telehealth visit meeting the requirements of the doctor-patient relationship is long-standing, but was pushed aside during the pandemic in the rush to adopt telehealth, when the federal government and every state relaxed guidelines on access and coverage to encourage more virtual care.
Now, with the federal public health emergency scheduled to expire later this year, some state governments are debating whether to make those emergency measures permanent. And some are pushing to crack down on what they see as an excessive use of telehealth.
“Today, telehealth is being done, but there are no guidelines, there is no foundation in the state of Alabama,” Alabama Rep. Paul Lee, a Republican who sponsored the House bill, told the House Health Committee he chairs, according to the Alabama Daily News. “It’s basically the wild, wild west.”
“I think there’s no substitute for in-person contact, for face-to-face contact, for actually talking to the patient, actually examining the patient,” Republican State Senator Larry Stutts said during a hearing on the Senate bill, as reported by the Alabama Political Reporter. “I don’t think there’s any replacement for actually seeing the patient, examining the patient.”
Across the country, the debate is especially contentious with abortion rights, with some states moving to make telemedicine abortions illegal while supporters argue the platform is safe and should be available for women who can’t easily access a care provider in person.
Another point of contention is the telephone, also called audio-only telehealth. While the rules were relaxed during the pandemic to allow providers to conduct some services by phone with patients, critics say the phone isn’t adequate enough to meet the requirements for a doctor-patient relationship.
In Alaska, a proposed bill would have required an in-person visit before any telehealth service. The bill was voted down in committee.
Supporters say the legislation would protect Alaska providers by curbing virtual care services from providers based in other states.
“I made a promise years ago working on a telehealth bill to Alaska physicians that I would never undercut them,” Republican State Senator Lora Reinbold told State of Reform. “This amendment keeps the promise that I made years ago. I truly believe that if we have all these doctors moving [services] up here, and they want to treat Alaskans, and we’re doing telemedicine, you miss so much. It is so important.”
Opponents, meanwhile, say the bill would reduce negatively affect healthcare access and quality.
“I actually want to introduce competition,” Republican State Senator Shelley Hughes said. “I don’t want to inhibit that. I love our in-state providers, but I do believe the health care cost situation has become so severe that we should not be trying to stop Alaskans from seeking more affordable care.”
Telehealth supporters argue that the provider should establish when in-person care is necessary, and that these bills would create barriers to access for underserved and rural patients who can’t easily get to the doctor’s office.
Many have petitioned both Congress and the Centers for Medicare & Medicaid Services to make those pandemic telehealth freedoms permanent, saying those services have been proven to boost access to care and, in some cases, improve clinical outcomes and provider workflows. They also argue that an abrupt end to those freedoms, as would happen when the public health emergency ends, would force health systems to shut down programs and patients to lose access to important services.
"One acknowledged bright spot resulting from COVID-19 has been the extraordinary use of telehealth that has allowed patients to access quality care from the convenience of their homes," Kyle Zebley, vice president of public policy for the American Telemedicine Association, said in a press release accompanying a letter signed by more than 430 organizations, including health systems, urging Congress to make those freedoms permanent.
"However, there is now much uncertainty around the future of telehealth, creating chaos and concern for patients and healthcare providers alike, as the 'telehealth cliff' threatens to abruptly cut off access to care, especially for our underserved and rural populations," he said.
Sri Bharadwaj, vice president of digital innovation and applications at Franciscan Health, is part of a new wave of healthcare executives focused on advancing a culture of virtual (and value-based) care
With virtual health becoming a mainstay in the healthcare landscape, more health systems are including innovation in their leadership structure. The management of new tools and technologies, as well as new strategies that aim to improve clinical care and fine-tune clinician workloads, often now falls to the chief innovation officer, the chief technology innovation officer, or the vice president of digital innovation.
Sri Bharadwaj leads that charge at Franciscan Health, a 12-hospital, 400-site health system based in Indiana. As vice president of digital innovation and applications since February of 2020, he’s been guiding the health system through an intense period of change, precipitated by the pandemic, along with what he says is the journey to value-based care.
“Central to this is change management,” he says. “It’s a critical component of how we operate, and how we will become a virtual hospital of the future.”
The operative word there is ‘change,’ and it’s a key component of the role that Bharadwaj and others like him play in transitioning healthcare to value-based care. He notes that among the biggest challenges to a health system’s acceptance of change is “relationship barriers,” or a reluctance within the organization to embrace new strategies.
“We have to rethink the status quo,” he says. COVID-19 “created an urgency to change and gave us a good look at what we have to do from now on to succeed, and we all have to play a part.”
It’s not an easy role. Just a few years ago, a Health Affairs study looked at the “relatively new” phenomena of the chief innovation officer, and concluded that they often face pushback from upper-level management in fostering innovation.
“If the goal of the chief innovation officer role is to truly catalyze transformation into new business models, organizations will need to be more ambitious in developing innovation structures, providing access to key stakeholders, and resourcing appropriately,” the report concluded.
And in a 2018 survey conducted by Kevin Schulman, a professor of medicine at the Clinical Excellence Research Center at Stanford University, and several colleagues from the Harvard Business School, roughly one-fifth of the health systems surveyed don’t have a chief innovation officer or appropriate position. With the rest, the position is seen as a strategic role, but often there’s a disconnect between appointing someone to the role and making an impact.
“The innovation literature has a growing focus on the role of organizational structure as a key enabling approach for organizations to consider, particularly for business transformation,” Schulman and his colleagues wrote. “Yet, in our study, only 20% of respondents reported that innovation included a novel organizational form. This result stands in contrast to an aspiration for transformative innovation in organizations, such as a shift to value-based payment models in health care. This result may limit the impact of these innovation efforts: ‘When innovators stop short of business model innovation, hoping that a new technology will achieve transformative results without a corresponding disruptive business model and without embedding it in a new disruptive value network or ecosystem, fundamental change rarely occurs.’ ”
Those challenges aside, the chief innovation officer role is gaining attention in healthcare circles. Chief innovation officers even have their own professional group. In 2018, the Healthcare Innovators Professional Society (HIPS) launched, with 36 executives from some of the most forward-thinking health systems in the country.
“I believed that the pace of innovation could go faster if these executives had access to a non-competitive network of peers with whom they could informally share thoughts and ideas, and work collectively to create solutions,” Toby Hamilton, MD, the group’s founder and executive director said in interview with HealthLeaders.
Sri Bharadwaj, vice president of digital innovation and applications at Franciscan Health. Photo courtesy Franciscan Health.
Bharadwaj says executives like him are starting to prove their value, in part, because COVID-19 emphasized the importance of telehealth and digital health innovation. Those health systems with innovation officers already in place were able to adapt to virtual care more easily at a time when that may have been all that stood between a hospital and complete chaos or closure, while others struggled to embrace not only the technology but the management structure behind it.
As we move beyond the pandemic, health system leaders are now focused on a future that combines virtual and in-person care in a hybrid platform, using new technologies and strategies that focus on remote data capture and care management.
“We’re affecting the entire continuum of care,” Bharadwaj says. “And we need to look around us and see how other industries are doing this. They’re all moving to a digital model.”
He says this digital transformation in healthcare is fueled in part by the shift to consumer-focused care. As consumers gain more control of their healthcare, including deciding how and where they access care, they’re putting pressure on care providers to offer options, such as telehealth visits and digital access to healthcare records, resources, and scheduling. If care providers aren’t willing to make changes, there’s a fast-growing network of new care providers, from retail clinics to telehealth vendors, willing to meet consumers' requests.
A health system’s innovation leader creates an atmosphere by which those changes can be made, Bharadwaj says. It starts with collaboration, in the form of discussions between management, clinicians, and others within the healthcare settings that identify gaps in care or barriers to effective care delivery. How those challenges can be addressed is not only with new technology but with strategies that consider cost, workflow management, and patient engagement. Innovation won’t succeed unless there’s proof in hand that it makes healthcare better.
And that’s where data comes into play.
“Data is the cornerstone to care,” Bharadwaj says. “That’s one of the things we’ve struggled with in the hospital system. We now have the ability to capture so much data, both inside and outside the [hospital], but how do we use it meaningfully?”
How a health system collects and uses data may be the key to whether an innovative new program like remote patient monitoring (RPM) catches on and becomes sustainable and scalable. Bharadwaj says that the data coming into the hospital can be used to paint a more complete and accurate picture of the patient, offering not only more opportunities for improved care management but new insights into preventive health and wellness that affect long-term patient engagement and outcomes.
“In the end, we’re not talking about a patient, but about a person,” he says.
Bharadwaj says the health system of the future won’t be confined to a hospital, clinic, or doctor’s office; he cites recent research by Gartner that predicts at least 40% of a hospital’s business will shift to the home by 2025.
In that landscape, a health system must lay the groundwork for more RPM programs, even the more ambitious hospital at home concept that sees some intensive care services shifted to the home, and it must have a strategy in place for vetting mHealth apps and other digital therapeutics prescribed by doctors, and wearables and telehealth services preferred by consumers.
“The hospital of the future will be high-acuity,” he says. “We have to be ready for this, and we have to make sure the home is ready as well. By 2025 or 2030, the patient will have the technology at home to accept virtual care, and we have to be ready to provide it.”
The Pennsylvania health system is partnering with a digital health company to test the value of the Passive Digital Marker is detecting early symptoms that may lead to dementia
The Geisinger health system is launching a study on the effectiveness of an AI tool in identifying cognitive impairment that could lead to dementia.
The Pennsylvania health system is teaming up with New Jersey-based Eisai on the project, which will study the value of the Passive Digital Marker on a set of de-identified data to identify which individuals are dealing with cognitive impairment. The algorithm was designed by researchers at Purdue University and Indiana University.
"As we continue to develop new treatments to prevent and slow the progression of Alzheimer's and related dementias, early detection is becoming even more important," Glen Finney, MD, director of Geisinger's Memory and Cognition Program and a board member of the Greater PA Chapter of the Alzheimer's Association, said in a press release. "Early and accurate diagnosis and treatment of these conditions can drastically improve outcomes and quality of life for both patients and caregivers."
More than 55 million people worldwide are living with dementia, and experts predict that number will rise to 78 million by 2030. In addition, some 40-60% of adults with probable dementia are undiagnosed.
Early detection and treatment can help patients improve their quality of life and potentially reduce healthcare costs and poor clinical outcomes later on, especially if the condition isn’t diagnosed. The technology could also help researchers better understand the root causes of dementia and other neurological conditions and aid in better treatments, perhaps even a cure.
"AI technology has the potential to transform medicine," Yasser El-Manzalawy, PhD, a principal investigator in the project and an assistant professor of translational data science and Informatics at Geisinger, said in the press release. "AI-based tools can efficiently scan massive amounts of healthcare data and identify hidden patterns. These patterns can be used to detect diseases, like cancer and dementia, at an early stage. Our data science research team is uniquely positioned to leverage this innovative technology to develop and validate tools to identify patients with unrecognized dementia or patients at high risk of developing dementia in the future."
The Hospital and Healthsystem Association of Pennsylvania has named the top three winners in a contest recognizing innovative programs launched to address care needs during the pandemic.
Three Pennsylvania health systems are being recognized for innovations they made during the pandemic to improve patient care.
The Hospital and Healthsystem Association of Pennsylvania (HAP), an organization of more than 240 healthcare organizations and other stakeholders in the Keystone State, announced the three winners – comprising four programs – in a contest in which more than 80 entries were judged.
“Pennsylvania hospitals have not only protected the health of their communities during this pandemic but have also been leaders in finding innovative solutions to the unprecedented challenges caused by COVID-19,” HAP President and CEO Andy Carter said in a press release. “These awards recognize the exceptional health care teams that developed creative strategies to meet their communities’ needs and address issues such as vaccine access, racial disparities in vaccination, and medical supply chain disruptions.”
The top three award-winners are:
The Children’s Hospital of Philadelphia, which led a partnership to facilitate early access to COVID-19 vaccines for school and childcare employees with a focus on enabling schools and childcare providers to resume in-person operations while helping to protect the health and safety of students and staff.
The Allegheny Health Network, which was selected for two projects. One addressed shortages of N-95 respirators by developing a strategy for equipping staff with industrial respirators that could be sterilized and reused. The other was a campaign to stage mass vaccination events across the greater Pittsburgh region with a commitment to ensuring access for marginalized and historically underserved communities.
Penn Medicine and Trinity Health Mid-Atlantic, which partnered on a project to address racial inequities in vaccine access by establishing rotating community vaccine clinics throughout the greater Philadelphia region that addressed environmental, socio-economic, and technology-related barriers to vaccine access.
The other health systems placing in the top 10 are Evangelical Community Hospital, Guthrie Healthcare, Jefferson Health, the Lehigh Valley Health Network, Main Line Health, and WellSpan Health.